U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07861191) titled 'RESET-INSPIRE Study: Insulin Sensitivity & Population Intervention With Real-time Evaluation Using CGM' on Sept. 25.
Brief Summary: The RESET-INSPIRE study is designed to investigate individual variability in glucose response and insulin sensitivity, a key mechanism underlying metabolic-associated steatotic liver disease (MASLD) and cardiometabolic disorders. Building on findings from Project RESET, this study aims to develop and validate a continuous glucose monitoring (CGM)-based approach for assessing insulin sensitivity.
Study Start Date: July 27
Study Type: OBSERVATIONAL
Condition:
Diabete Mellitus
MASLD
Recruitment Status:...